Biomea Fusion BMEA
NASDAQ BMEA
$0.55 -0.05 (-7.56%)
As of: Nov 10, 2026 · 2:44 PM EST

Biomea Fusion (BMEA) Revenue (2024 - 2026)

Updated

Analysis

Biomea Fusion (BMEA) Revenue (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 25.40 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 17.40 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 15.38 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 8.30 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 16.58 Bn
10 Biomea Fusion 43.49 Mn -138.85 Mn - 319,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 319,000.00
Mar 31, 2026 430,000.00
Dec 31, 2025 -3.53 Mn
Sep 30, 2025 4.40 Mn
Jun 30, 2025 309,000.00
Mar 31, 2025 450,000.00
Dec 31, 2024 772,000.00
Sep 30, 2024 1.25 Mn
Jun 30, 2024 1.62 Mn
Mar 31, 2024 2.00 Mn
API Access

Biomea Fusion Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=BMEA&period=max&api_key=YOUR_API_KEY